Table 2.
Comparison of treatment results between rTMS and tDCS.
| Immediately After | 1 Month After | |||||
|---|---|---|---|---|---|---|
| rTMS | tDCS | p-Value | rTMS | tDCS | p-Value | |
| VAS lo | 6.3 ± 2.4 | 6.8 ± 2.0 | 0.517 | 6.1 ± 2.0 | 6.1 ± 1.8 | 0.990 |
| VAS aw | 6.7 ± 2.1 | 7.2 ± 2.1 | 0.276 | 6.4 ± 2.2 | 6.1 ± 1.8 | 0.493 |
| VAS an | 5.8 ± 2.4 | 5.6 ± 2.5 | 0.956 | 5.9 ± 2.7 | 5.0 ± 2.2 | 0.131 |
| THI | 46.1 ± 23.8 | 47.5 ± 23.3 | 0.714 | 42.2 ± 19.6 | 40.6 ± 20.4 | 0.745 |
| Improvement ratio 1 | 11/23/2 | 4/29/0 | 0.054 | 17/17/2 | 12/18/3 | 0.618 |
1 “Improvement rate” values indicate improvement/no change/worsening.